DC
EGRX

Deere & Company’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Deere & Company’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,901
Closed -$639K – 1063
2015
Q2 		$639K Sell
7,901
-6,524
-45% -$425K 0.03% 534
2015
Q1 		$604K Buy
+14,425
New +$409K 0.03% 550

Other funds holding EGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

Deere & Company's EGRX Position: Q3 2015 in Review

Deere & Company sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2015, closing a stake of 7,901 shares — an estimated $639K sold.

Deere & Company first reported a position in EGRX in Q1 2015 and held it in 2 quarters. The position peaked at $639K in Q2 2015. 119 funds tracked by Wall St. Rank hold EGRX as of Q3 2015.

  • Deere & Company reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Deere & Company sold 7,901 Eagle Pharmaceuticals, Inc. shares in Q3 2015, an estimated $639K.
  • Deere & Company first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2015 and held it in 2 quarters.
  • Deere & Company's Eagle Pharmaceuticals, Inc. position peaked at $639K in Q2 2015.
  • 119 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2015.

Based on Deere & Company's 13F filing for Q3 2015, filed 12 Nov 2015.